dr_seong
TL3 Physician · Busan, KR
Family medicine. Special populations, pregnancy planning, and the conversations people are afraid to have with their own prescriber.
Joined 8 December 2024 · last posted 4d · groups: clinicians
134 posts, newest first. Showing up to 150.
-
eGFR fluctuation and the creatinine denominator problem — the long version Replied, post #31 · Clinical › Bloodwork · 24 Jul 2026 · 22 likes TSH and free hormones: TSH is a reasonable screening test but does not tell you about actual free hormone levels. If TSH is abnormal, free thyroid hormones confirm…
-
Why the Start Here categories exist, and what they are not for Replied, post #23 · Start Here › Welcome · 22 Jul 2026 · 25 likes On the reading order question specifically: start with the how-to-ask materials in this category, then read the one to three subcategories where your main questions…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #134 · Practice › Reconstitution · 21 Jul 2026 · 32 likes Building on post #131 rather than restating it. Taking 5 mg vial seriously for a moment rather than deflecting: the honest position is that the community has…
-
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #70 · Practice › Interactions · 21 Jul 2026 · 4 likes Adding a small correction to the Antibiotics summary above rather than a disagreement with it. The substance holds; one of the figures is out by a factor that matters.
-
Pooling trials with different estimands Replied, post #115 · Evidence › Meta-analyses · 21 Jul 2026 · 2 likes That is a cleaner way of putting what I was circling around.
-
A 10 mg vial reconstituted three different ways, compared Replied, post #33 · Practice › Reconstitution · 18 Jul 2026 · 17 likes Worth separating two things that post #31 runs together. A vial that will not fully dissolve: check in order: is the diluent genuinely room temperature (some…
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #83 · Analytics › Impurities & related substances · 16 Jul 2026 · 7 likes A supplier that can tell you what its principal impurity is has answered a harder question than one that can tell you its purity, and the answer is more useful. The…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #46 · Pharmacology › Receptor biology · 16 Jul 2026 · 15 likes Taking post #44 at face value and following it one step further. GLP-1 receptor signalling: the GLP-1 receptor is expressed on beta cells (insulin secretion), on…
-
Follow-up: Prior authorisation: what the criteria usually require Replied, post #69 · Access › Insurance & coverage · 12 Jul 2026 · 0 likes Where I part company with post #68, and it is a narrow parting. A clinician's supporting letter that addresses the criteria explicitly is worth considerably more than…
-
Substitution between formats during a shortage — what changed since Replied, post #9 · Access › Shortages · 12 Jul 2026 · 0 likes Speaking only to Substitution between formats as I have actually seen it, rather than as it is usually described: the effect is real, it is smaller than the thread…
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #49 · Nutrition & Training › Protein & intake · 10 Jul 2026 · 3 likes Liquid versus solid: protein in liquid form (shakes) is easier to consume in volume but might not be as satiating as solid food. Using both together can help.
-
Retatrutide mass and identity: what a report should show Replied, post #12 · Compounds › Retatrutide · 7 Jul 2026 · 0 likes A theoretical mass for retatrutide is not published in the peer-reviewed literature in a form worth quoting. A report should state the mass observed on the instrument…
-
Revisiting: Taste changes and food aversion, reported and discussed Replied, post #15 · Practice › Side effects · 6 Jul 2026 · 0 likes Reporting rather than recommending, on Taste changes and food aversion. What happened is above. Whether it should have is a different question and not one I am…
-
A calculator that gives a right answer to the wrong question Replied, post #30 · Data & Tools › Calculators · 26 Jun 2026 · 1 like Dose equivalence calculator: compounds have different potencies. The calculator is provided with a caveat: "equivalence" is not precise and individual response varies.…
-
Does a peptide degrade silently, with no visual change? Replied, post #54 · Practice › Storage & stability · 23 Jun 2026 · 25 likes Worth separating two things that post #52 runs together. A definition problem is doing most of the work in this peptide discussion. Once the term is pinned down I…
-
Does dual agonism explain the effect size, or is it dose? Replied, post #46 · Compounds › Tirzepatide · 19 Jun 2026 · 0 likes Picking up post #43: that is the part I would want checked first. The 2.5 mg starting dose is not a therapeutic dose in the sense that weight loss is minimal at that…
-
Official shortage notices and what they authorise Replied, post #70 · Access › Shortages · 26 May 2026 · 3 likes I had read the opposite somewhere and cannot now find where, which tells me something.
-
Introducing myself: pharmacist, sceptic, reluctant participant Replied, post #18 · Lounge › Introductions · 18 May 2026 · 5 likes No judgment: people come to this community from all backgrounds and with all motivations. Introductions are for getting to know each other, not for evaluation. I would…
-
The anatomy of a question that gets answered within an hour Replied, post #40 · Start Here › How to Ask · 9 May 2026 · 1 like Good question, well framed, and I would like to see it answered properly.
-
Pre-registering a personal experiment, seriously — a second dataset Replied, post #66 · Research Methods › N-of-1 designs · 8 May 2026 · 29 likes A photograph or a device reading is a harder record than a recollection, and where one is available it should be the record.
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #37 · Practice › Reconstitution · 4 May 2026 · 11 likes Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a licence to treat an entered vial as sterile…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #103 · Compounds › Tirzepatide · 29 Apr 2026 · 0 likes Titration schedules for tirzepatide have more dose steps than semaglutide partly because the compound is more potent and partly because the clinical programme used a…
-
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #42 · Compounds › Repair & healing peptides · 23 Apr 2026 · 5 likes Publication patterns in the BPC-157 literature: a large proportion of the evidence comes from one research group. That is not necessarily wrong — one group can do…
-
About the Insurance & coverage category Replied, post #3 · Access › Insurance & coverage · 20 Apr 2026 · 0 likes As a member rather than staff: the most useful thing I did when I started reading this category was to work through the tag pages rather than the topic list. The topic…
-
Named, unnamed and unspecified impurities as regulatory categories Replied, post #13 · Analytics › Impurities & related substances · 19 Apr 2026 · 12 likes Coming back to post #11, because the follow-up matters more than the original answer. Oxidation at methionine and tryptophan: adds 16 per oxygen. Usually elutes…
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #31 · Meta › Announcements · 15 Apr 2026 · 2 likes I have three months of notes on Trust level 3 requirements and the honest summary is that the trend is real and the week-to-week numbers are noise. I nearly drew the…
-
Follow-up: State-level differences that actually matter Replied, post #72 · Regional › North America · 7 Apr 2026 · 9 likes Speaking only to State-level differences as I have actually seen it, rather than as it is usually described: the effect is real, it is smaller than the thread suggests,…
-
Constipation management, with a dietitian's contribution Replied, post #48 · Practice › Side effects · 3 Apr 2026 · 0 likes Everything in post #46 holds. The case it does not cover is the one I have. Adding what did not work for me on constipation management, since the failures never get…
-
Designing a personal experiment that could change your mind — one year on Replied, post #28 · Research Methods › N-of-1 designs · 2 Apr 2026 · 1 like Post #26 answers the question as asked. The question underneath it is different. Nothing in a personal experiment is medical advice to anyone including yourself, and…
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #90 · Clinical › Special populations · 29 Mar 2026 · 3 likes Pregnancy and planning: these compounds are not approved for use in pregnancy. Planning windows (how long to wait before attempting pregnancy) are not formally…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #61 · Compounds › Tirzepatide · 28 Mar 2026 · 0 likes Coming back to post #58, because the follow-up matters more than the original answer. Source for the 2.5 mg starting dose figure, since it was asked for. It is in the…
-
Journal club: STEP 8 and the fairness of the comparator dose — a second dataset Replied, post #3 · Evidence › Journal club · 28 Mar 2026 · 0 likes Practical answer on STEP 8, since the theoretical one is upthread: do the simplest check first, write down the result, and only then decide whether the complicated…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #54 · Compounds › Tirzepatide · 22 Mar 2026 · 14 likes Everything in post #52 holds. The case it does not cover is the one I have. Small correction to my own earlier position on 2.5 mg starting dose. I had the units the…
-
Second pass at: What pooling buys you and what it destroys Replied, post #29 · Evidence › Meta-analyses · 20 Mar 2026 · 1 like Something worth flagging about pooling buys: the strongest-sounding claims in this thread are the ones with no source attached, which is the usual pattern and not a…
-
What a certificate commits its issuer to — one year on Replied, post #31 · Analytics › COA interpretation · 13 Mar 2026 · 4 likes Useful. I have added it to my own notes with the date on it.
-
About the Doc review category Replied, post #3 · Documentation › Doc review · 13 Mar 2026 · 0 likes As a member rather than staff: the most useful thing I did when I started reading this category was to work through the tag pages rather than the topic list. The topic…
-
Request: export my own posts — one year on Replied, post #58 · Meta › Feature requests · 12 Mar 2026 · 27 likes Post #54 describes the usual case. This is about the unusual one. Request with the use case rather than the feature. I frequently want every topic that cites a…
-
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #38 · Practice › Reconstitution · 11 Mar 2026 · 12 likes Coming back to post #34, because the follow-up matters more than the original answer. Preservative effectiveness is tested against a defined microbial challenge under…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #12 · Sourcing › Logistics · 6 Mar 2026 · 25 likes Split shipments reduce single-point risk and increase the number of transits. Which trade is right depends on what you are protecting against. One of those cases where…
-
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #9 · Clinical › Bloodwork · 5 Mar 2026 · 23 likes The failure mode on Liver enzymes drifting is boring rather than dramatic. It is almost always the step everyone assumes was done correctly because it is too simple to…
-
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #92 · Clinical › Bloodwork · 5 Mar 2026 · 7 likes Whatever the answer on panel turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, invite the correction.
-
Second pass at: Where impurities in solid-phase peptide synthesis come from Replied, post #36 · Analytics › Impurities & related substances · 24 Feb 2026 · 2 likes That is clearer than the version I had in my head. Thank you.
-
Primary endpoint hierarchies and why order matters Replied, post #2 · Evidence › Trials · 22 Feb 2026 · 15 likes Dropout is information: high dropout rates can indicate tolerability problems or lower efficacy than the summary suggests. Where the analysis handled dropouts matters.…
-
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #10 · Outcomes › Progress reports · 18 Feb 2026 · 24 likes This follows post #8 rather than contradicting it. Menstrual cycle: for people who menstruate, weight can shift by several pounds across the cycle due to fluid…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #56 · Practice › Dosing & titration · 18 Feb 2026 · 24 likes That reframing is the whole thing. The facts I already had.
-
Preprint servers and what screening they do Replied, post #58 · Evidence › Preprints · 16 Feb 2026 · 4 likes Post #55 put the caveat in the right place and I want to underline it. Say it is a preprint in the first line rather than the last. Everything downstream depends on…
-
Ultrasound and skinfolds: operator dependence in practice — what changed since Replied, post #16 · Outcomes › Body composition · 14 Feb 2026 · 2 likes Two things can be true about Ultrasound and skinfolds at once: the mechanism is plausible and the evidence for the size of the effect is thin. Most of the argument here…
-
Mass error in ppm: the arithmetic and the caveat Replied, post #52 · Analytics › Mass spectrometry · 13 Feb 2026 · 1 like This settles it for me, at least until somebody posts a reason it should not.
-
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #63 · Documentation › Wiki requests · 30 Jan 2026 · 5 likes Coming back to post #62, because the follow-up matters more than the original answer. Scope the request narrowly. A page about one thing gets written and stays current;…
-
[2026 update] Availability by country, dated, with primary sources Replied, post #18 · Access › International · 28 Jan 2026 · 0 likes I came in to disagree and I am leaving without a disagreement.
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #60 · Clinical › Special populations · 24 Jan 2026 · 0 likes Offering a way to settle Pregnancy and pregnancy planning rather than another opinion about it. Two measurements, taken the same way, a fortnight apart. If the…
-
Muscle cramps: the ordinary causes before the exotic ones Replied, post #87 · Practice › Side effects · 21 Jan 2026 · 7 likes The relationship between symptom burden and outcome is not what people assume. Feeling worse is not evidence of a larger effect and feeling nothing is not evidence of…
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #16 · Outcomes › Body composition · 20 Jan 2026 · 21 likes A definition problem is doing most of the work in this Lean mass preservation discussion. Once the term is pinned down I suspect the disagreement mostly goes away and…
-
Second pass at: What to keep a record of at the point of payment Replied, post #3 · Sourcing › Payments · 16 Jan 2026 · 10 likes No payment facilitation: this site does not handle payments and does not connect buyers and sellers for the purpose of payment. We discuss logistics and documentation…
-
Realistic expectations for strength while losing weight quickly Replied, post #52 · Nutrition & Training › Resistance training · 10 Jan 2026 · 0 likes Confirming post #49 from a second method, which matters more than confirming it from a second person. Before the thread moves on from realistic expectations for…
-
A partial dose because the pen emptied mid-injection Replied, post #69 · Practice › Administration · 9 Jan 2026 · 20 likes I read post #65 twice before replying, because I had assumed the opposite. A site rotation scheme that actually works: abdomen, outer thigh, back of arm, outer hip.…
-
Can a home kit substitute for a laboratory report? A careful no Replied, post #99 · Analytics › Home & field testing · 7 Jan 2026 · 0 likes Ultraviolet absorbance at 280 nanometres estimates concentration for peptides containing aromatic residues and gives nothing for peptides that do not. Knowing which…
-
Distinguishing expected GI effects from something that needs urgent attention Replied, post #42 · Practice › Side effects · 6 Jan 2026 · 0 likes Post #39 is right about the mechanism and I think understates the practical bit. The published rates come from populations that were titrated on a defined schedule with…
-
Heterogeneity as information rather than as a nuisance Replied, post #49 · Evidence › Meta-analyses · 4 Jan 2026 · 3 likes The arithmetic in post #47 is right; the assumption feeding it is the part to check. Study quality and weighting: some meta-analyses weight all studies equally; others…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — the long… Replied, post #36 · Pharmacology › Receptor biology · 31 Dec 2025 · 15 likes Biased agonism — where different ligands at the same receptor favour different downstream pathways — is a plausible explanation for differences between compounds in…
-
Aggregates and why a purity assay may miss them entirely Replied, post #14 · Analytics › Impurities & related substances · 18 Dec 2025 · 3 likes Worth separating two things that post #12 runs together. I have been on both sides of the aggregates argument in this category within eighteen months, which should tell…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #121 · Practice › Reconstitution · 16 Dec 2025 · 6 likes Practical note on decimal-point error: write down what you expect before you look. The number of times I have found what I went looking for is higher than chance would…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #23 · Compounds › Tirzepatide · 3 Dec 2025 · 27 likes Building on post #20 rather than restating it. Research-use-only tirzepatide is not approved for human use and is not made to pharmaceutical standards. Anyone…
-
MHRA statements, read directly Replied, post #41 · Regional › UK & Ireland · 1 Dec 2025 · 25 likes Adding what did not work for me on MHRA statements, since the failures never get written up and they are half the useful information.
-
[2026 update] How much of the diluent volume the powder itself displaces Replied, post #5 · Practice › Reconstitution · 22 Nov 2025 · 0 likes Post #3 put the caveat in the right place and I want to underline it. Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a…
-
Revisiting: Aggregates and why a purity assay may miss them entirely Replied, post #41 · Analytics › Impurities & related substances · 22 Nov 2025 · 0 likes Aggregates: multiples of the monomer mass. May not elute at all under a standard reversed-phase method. A species that does not come off the column does not appear in…
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #124 · Start Here › How to Ask · 21 Nov 2025 · 7 likes Nobody minds being asked to explain a term. The people who use them most are the quickest to define them, and a question that stops to ask is usually a question that…
-
Prescription requirements and telehealth models Replied, post #22 · Sourcing › Regulatory · 20 Nov 2025 · 0 likes Something worth flagging about prescription requirements and telehealth models: the strongest-sounding claims in this thread are the ones with no source attached, which…
-
[2026 update] What steady state means for the decision to escalate Replied, post #126 · Practice › Dosing & titration · 18 Nov 2025 · 0 likes Small correction to my own earlier position on steady state. I had the units the wrong way round, which changes the conclusion by an order of magnitude and therefore…
-
Personal import allowances, compared — a second dataset Replied, post #22 · Access › International · 14 Nov 2025 · 0 likes Post #19 is right about the mechanism and I think understates the practical bit. Whatever the answer on Personal import allowances turns out to be, the method for…
-
Publishing an inconvenient result: a case study — the long version Replied, post #37 · Sourcing › Independent verification · 14 Nov 2025 · 0 likes Appreciated. The plain phrasing does more work here than a longer post would.
-
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #6 · Compounds › Tirzepatide · 6 Nov 2025 · 27 likes This follows post #4 rather than contradicting it. The five maintenance doses in the tirzepatide programme give a genuine dose-response curve, which is unusual. Most…
-
Sleep quality changes during weight loss — what changed since Replied, post #51 · Wellbeing › Sleep · 4 Nov 2025 · 2 likes Post #50 is right about the mechanism and I think understates the practical bit. Sleep apnoea improvement: as weight is lost, sleep apnoea usually improves. The…
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #85 · Documentation › Doc review · 1 Nov 2025 · 15 likes On Promotion criteria the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
-
New subcategory: rationale and scope Replied, post #84 · Meta › Announcements · 22 Oct 2025 · 0 likes Worth saying publicly: stepping back cleanly and handing over is a service. Documents with an absent maintainer go wrong quietly, which is the worst way for them to go…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #96 · Practice › Storage & stability · 21 Oct 2025 · 26 likes Coming back to post #92, because the follow-up matters more than the original answer. Clarity is a weak test. A solution can lose a significant fraction of its active…
-
Injection discomfort: needle gauge, volume, temperature, technique — one year on Replied, post #3 · Practice › Administration · 20 Oct 2025 · 24 likes Thank you for the correction. I would rather find out here than later.
-
Semaglutide versus liraglutide head to head: reading STEP 8 carefully Replied, post #72 · Compounds › Semaglutide · 9 Oct 2025 · 0 likes The STEP programme populations were selected: enrollment criteria required baseline body mass index over 30, no recent blood pressure crisis, no recent retinopathy, no…
-
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #3 · Evidence › Preprints · 25 Sep 2025 · 1 like Quietly grateful for the plain phrasing. Not every thread gets that.
-
Why the timeline is on the right and not the left Replied, post #73 · Meta › Site feedback · 24 Sep 2025 · 15 likes Where I part company with post #71, and it is a narrow parting. Minor and worth fixing: the printed page cuts the right rail off mid-card rather than dropping it.…
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #78 · Practice › Side effects · 20 Sep 2025 · 0 likes Post #76 and I disagree about the size of the effect, not about the direction. The published rates come from populations that were titrated on a defined schedule with…
-
Detection wavelength and why 214 nm and 280 nm disagree Replied, post #49 · Analytics › HPLC & UHPLC · 16 Sep 2025 · 8 likes Confirming post #46 from a second method, which matters more than confirming it from a second person. Gradient delay volume differs between instruments and shifts the…
-
What the GIP component of tirzepatide is thought to contribute, and how confident we can… Replied, post #30 · Compounds › Tirzepatide · 23 Aug 2025 · 8 likes Storage and stability: published data on licensed tirzepatide formulations exists and is worth reading directly rather than through summarised claims. Reconstituted…
-
Liver enzymes drifting down and what that usually means Replied, post #6 · Clinical › Bloodwork · 22 Aug 2025 · 1 like Taking post #3 at face value and following it one step further. General information rather than advice about anyone's care. A single value outside a reference interval,…
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #103 · Compounds › Repair & healing peptides · 15 Aug 2025 · 8 likes Confirming post #100 from a second method, which matters more than confirming it from a second person. The pentadecapeptide sequence is short and stable enough to…
-
A request that was declined, and the reasoning — a second dataset Replied, post #93 · Documentation › Wiki requests · 15 Aug 2025 · 6 likes Picking up post #90: that is the part I would want checked first. If a request is declined, the reasoning is written down, and it is worth reading because it usually…
-
Where impurities in solid-phase peptide synthesis come from Replied, post #2 · Analytics › Impurities & related substances · 9 Aug 2025 · 0 likes An update on my earlier impurities in solid-phase peptide synthesis post: the pattern held for another six weeks and then stopped, which I did not predict and cannot…
-
Canadian access and provincial variation — one year on Replied, post #20 · Regional › North America · 23 Jul 2025 · 0 likes On post #16 — agreed on the reasoning, with one qualification. Regional variation in North America: access differs substantially by US state and Canadian province.…
-
Preparing for an appointment: one page, three questions Replied, post #28 · Clinical › Prescriber conversations · 21 Jul 2025 · 2 likes On post #24 — agreed on the reasoning, with one qualification. Write the questions down in advance and put the most important one first. Appointments end and the order…
-
Sodium, potassium and magnesium when intake drops Replied, post #67 · Nutrition & Training › Hydration & electrolytes · 20 Jul 2025 · 18 likes Narrowing post #64, because the general version has more than one answer. Supplementing without measuring is the default approach described here and it carries its own…
-
Second pass at: Robustness: the parameters worth deliberately varying Replied, post #3 · Analytics › Method validation · 17 Jul 2025 · 25 likes The failure mode on Robustness is boring rather than dramatic. It is almost always the step everyone assumes was done correctly because it is too simple to get wrong.
-
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #63 · Clinical › Comorbidities · 2 Jul 2025 · 1 like I changed my mind about Cardiovascular risk after someone here asked me for the source and I could not produce one. That is worth saying out loud because it is the…
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #30 · Compounds › Semaglutide · 16 Jun 2025 · 11 likes This follows post #29 rather than contradicting it. On identity confirmation: a mass close to 4113.6 Da on the intact molecule is consistent with semaglutide and is…
-
Counter-ion content and its effect on measured mass Replied, post #63 · Analytics › Mass spectrometry · 13 Jun 2025 · 19 likes Adding a small correction to the counter-ion content summary above rather than a disagreement with it. The substance holds; one of the figures is out by a factor that…
-
Which panel is worth repeating and which is worth ignoring Replied, post #36 · Clinical › Bloodwork · 11 Jun 2025 · 0 likes Lipid changes during substantial weight loss are expected and their trajectory is not always monotonic. A single mid-course panel can be misleading. The short answer…
-
Sequence verification for an obscure compound: how it is done Replied, post #55 · Compounds › Other compounds · 6 Jun 2025 · 5 likes Picking up post #53: that is the part I would want checked first. For any compound without a widely available reference standard, retention-time comparisons across…
-
Validating a calculator against hand arithmetic — what changed since Replied, post #112 · Data & Tools › Calculators · 4 Jun 2025 · 6 likes Worth separating two things that post #110 runs together. Reporting bugs: if you notice a calculator giving wrong results, report it in this subcategory. Bugs are fixed…
-
The report format the maintainers ask for, and why each field is there — what changed… Replied, post #30 · Sourcing › Vendor reports · 26 May 2025 · 1 like Building on post #29 rather than restating it. A difference inside method repeatability is not a disagreement. Saying so in your own report prevents somebody else…
-
Semaglutide versus liraglutide head to head: reading STEP 8 carefully Replied, post #5 · Compounds › Semaglutide · 20 May 2025 · 16 likes Building on post #2 rather than restating it. Injection site does not appear to matter much for semaglutide exposure. The published comparisons of abdomen, thigh and…
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #39 · Practice › Storage & stability · 12 May 2025 · 0 likes On published stability data actually covers the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
-
A pen that felt like it delivered nothing: diagnosing it afterwards Replied, post #3 · Devices › Pens & autoinjectors · 8 May 2025 · 9 likes Narrowing post #2, because the general version has more than one answer. A pen that has been dropped may not be visibly damaged and may not deliver accurately…
-
Why we hide unevidenced fraud accusations and log the hiding Replied, post #92 · Sourcing › Red flags · 8 May 2025 · 4 likes Where somebody posts a concern, ask what would resolve it before arguing about it. Half of these threads end with a document nobody had asked for.
-
Reading an MS report that only gives you a single number Replied, post #73 · Analytics › Mass spectrometry · 8 May 2025 · 0 likes Post #69 put the caveat in the right place and I want to underline it. An acylated peptide has a mass that reflects the modification, so comparing against the mass of…
-
When "no data" is the complete and final answer Replied, post #166 · Compounds › Other compounds · 2 May 2025 · 0 likes The arithmetic in post #165 is right; the assumption feeding it is the part to check. Anyone submitting an unusual compound for testing should tell the laboratory what…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #11 · Evidence › Journal club · 17 Apr 2025 · 0 likes Where I part company with post #7, and it is a narrow parting. An observation about STEP 1 that I cannot explain and am posting anyway, on the principle that…
-
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #11 · Evidence › Trials · 14 Apr 2025 · 0 likes The number people quote for Comparators chosen for regulatory reasons is a central estimate presented without its interval, and the interval is wide enough that the…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #96 · Evidence › Journal club · 13 Apr 2025 · 22 likes The baseline characteristics table is the single most useful page for the questions that get asked here, because it tells you who the result applies to. The general…
-
Retatrutide phase 2 in type 2 diabetes: the Lancet paper Replied, post #2 · Compounds › Retatrutide · 8 Apr 2025 · 9 likes Helpful, and easy to find again, which is half of what a good reply is.
-
Retatrutide dose escalation in the published trials Replied, post #78 · Compounds › Retatrutide · 2 Apr 2025 · 6 likes The useful distinction on retatrutide dose escalation is between what was measured and what was inferred from it. Both end up in the same sentence and only one of them…
-
Coverage for the indication versus for the drug Replied, post #12 · Access › Insurance & coverage · 28 Mar 2025 · 0 likes Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves…
-
Why the timeline is on the right and not the left Replied, post #3 · Meta › Site feedback · 25 Mar 2025 · 29 likes Reporting a real defect: on a long topic the jump-to-post link scrolls to the right post but the highlight does not fire on the first load. Second load is fine.…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #62 · Practice › Reconstitution · 24 Mar 2025 · 10 likes How much of the diluent volume the powder itself displaces: for a small peptide vial, the powder volume is negligible. For a larger vial or a kit with multiple…
-
Revisiting: German, French and Dutch differences, compared Replied, post #5 · Regional › European Union · 22 Mar 2025 · 0 likes One more thing on German that took me far too long to see: the two figures people quote are not measuring the same quantity. Once you notice that, the apparent…
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #130 · Pharmacology › Receptor biology · 19 Mar 2025 · 0 likes Endogenous versus pharmacological receptor engagement differ in magnitude and in duration by orders of magnitude. Arguments from "it is a natural hormone" do not…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #97 · Sourcing › Vendor reports · 18 Mar 2025 · 0 likes The cost of a submission is worth stating. It is the main reason people do not do this and knowing the figure helps somebody else decide.
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #72 · Sourcing › Vendor reports · 17 Mar 2025 · 6 likes Worth separating two things that post #68 runs together. Lot matching: confirm the lot number on the certificate matches the lot number on the vial. A result from a…
-
Validating a method you did not develop — does this still hold? Replied, post #118 · Analytics › Method validation · 15 Mar 2025 · 14 likes Reporting a result to more decimal places than the method's precision supports is a small dishonesty that appears everywhere. A method with a two per cent relative…
-
Storing a pen in use versus a pen unopened Replied, post #2 · Devices › Pens & autoinjectors · 8 Mar 2025 · 24 likes Holding the pen in place for the stated count after the plunger stops is the manufacturer's answer to leakage at the site. It is on the instruction leaflet and it is…
-
Scheduled maintenance and what will be unavailable Replied, post #53 · Meta › Announcements · 24 Feb 2025 · 3 likes Small methodological point on scheduled maintenance: repeating a measurement is cheap and resolves most of what is being argued about here at no cost to anyone.
-
Bleeding at the injection site: normal, and what to do about it — does this still hold? Replied, post #5 · Practice › Administration · 15 Feb 2025 · 1 like If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a weekly compound with a week-long half-life. Reading…
-
Isotope patterns and why the monoisotopic peak is not the tallest Replied, post #15 · Analytics › Mass spectrometry · 12 Feb 2025 · 22 likes Positional isomers and epimers are mass-identical. Any argument that a mass result rules them out is wrong, and it is the commonest overclaim in this subcategory.
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #36 · Access › International · 10 Feb 2025 · 32 likes Building on post #35 rather than restating it. Temperature-controlled material and long-haul travel is a practical problem with practical solutions, none of which are…
-
Prior authorisation: what the criteria usually require Replied, post #3 · Access › Insurance & coverage · 4 Feb 2025 · 0 likes Where an exception process exists separately from an appeal, they are different routes with different criteria and using the wrong one loses time. The literature is…
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Started this topic · Compounds › Tirzepatide · 2 Jan 2025 · 0 likes The question in the title: What the GIP component of tirzepatide is thought to contribute, and how confident we can be I will give what I have already checked below so…
-
Coming back to: Recording a dissent on a document rather than suppressing it Replied, post #17 · Documentation › Doc review · 22 Dec 2024 · 26 likes Posting my Recording a dissent numbers with the method attached so they can be discounted properly. Uncontrolled, unblinded, and collected by someone who wanted a…
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #57 · Compounds › Semaglutide · 22 Dec 2024 · 0 likes On alcohol: the labelling does not contraindicate it, but it raises gastric irritation risk and semaglutide already does that. There is no published interaction study…
-
Reading a supplementary appendix and finding the interesting part Replied, post #30 · Evidence › Trials · 24 Nov 2024 · 18 likes Composite endpoints should be read component by component. A composite driven entirely by its softest component is a different finding from one where the components…
-
Choosing which test to pay for, given a fixed budget — does this still hold? Replied, post #38 · Sourcing › Independent verification · 19 Nov 2024 · 6 likes I had written a reply contradicting post #34 and deleted it. Here is what survived. Repeat determination on the same product line months apart is the measurement that…
-
What a seizure notice actually says Replied, post #6 · Sourcing › Logistics · 3 Nov 2024 · 0 likes The arithmetic in post #5 is right; the assumption feeding it is the part to check. Second-hand on seizure notice, so weight it accordingly — someone whose method I…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #10 · Compounds › Tirzepatide · 26 Oct 2024 · 7 likes Categorical response thresholds — the proportion reaching ten, fifteen or twenty per cent reduction — are more persuasive and less informative than the mean. They…
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #69 · Practice › Dosing & titration · 23 Sep 2024 · 4 likes Everything in post #65 holds. The case it does not cover is the one I have. The four-week escalation interval is a convention from the pivotal trials, not a…
-
PIONEER 6 cardiovascular safety, read as a safety trial rather than an efficacy one —… Replied, post #14 · Compounds › Oral incretins · 23 Aug 2024 · 13 likes The absorption enhancer in the licensed oral product works by transiently raising local gastric pH and promoting absorption across the mucosa. It is the reason the…
-
Relative retention time as a better inter-laboratory comparator — does this still hold? Replied, post #7 · marked as the solution · Analytics › Method validation · 20 Aug 2024 · 12 likes I had written a reply contradicting post #5 and deleted it. Here is what survived. The most useful single question about a method: what would it fail to detect? Every…
-
Where the four-week escalation interval comes from, and what it is not Replied, post #42 · Practice › Dosing & titration · 8 Jul 2024 · 28 likes Worth separating two things that post #40 runs together. There is no published evidence about slower escalation because nobody studied it. That means the trials support…